Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial translational activator MSS51 is a nuclear-encoded protein that localizes to the mitochondria and is essential for the specific translation of the COX1 mRNA, which encodes cytochrome c oxidase subunit 1, a core component of the mitochondrial respiratory chain[1][2]. MSS51 acts at both the untranslated regions (UTRs) and coding sequence of mitochondrial COX1 mRNA, directly promoting translation of COX1 and physically interacting with nascent Cox1 protein. This dual role allows it to couple Cox1 protein synthesis with its assembly into the cytochrome c oxidase complex, effectively providing a regulatory checkpoint that helps maintain mitochondrial respiratory efficiency and protein homeostasis[2]. While formally characterized in Saccharomyces cerevisiae, a homologous gene (ZMYND17) exists in humans, but its functional role remains unclear. No current therapeutic targeting or disease associations are established for MSS51, and it is not considered a druggable target or a receptor[1][2].
Not applicable (no direct drugs known to target MSS51)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial translational activator MSS51 (MSS51).